טוען...
Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats
BACKGROUND: Diabetic patients, through incompletely understood mechanisms, endure exacerbated ischemic heart injury compared to non-diabetic patients. Intermedin (IMD) is a novel calcitonin gene-related peptide (CGRP) superfamily member with established cardiovascular protective effects. However, wh...
שמור ב:
Main Authors: | , , , , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
BioMed Central
2013
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3703263/ https://ncbi.nlm.nih.gov/pubmed/23777472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-12-91 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|